Hevolution invests $20 million in Aeovian Pharmaceuticals to fight ageing
Longevity Technology - 28-Mar-2024Funds to advance compounds that target mTORC1 pathway for treating rare and age-related conditions
Mehmood Khan
Chief Executive Officer at Hevolution Foundation
Dr. Mehmood Khan’s distinguished career has included several senior corporate roles, including Vice Chairman and Chief Scientific Officer of Global Research and Development at PepsiCo, and President of Global R&D at Takeda Pharmaceuticals.
Before moving into the private sector Dr. Khan was a faculty member in endocrinology at the Mayo Clinic and Mayo Medical School where he served as Director of the Diabetes, Endocrine and Nutritional Trials Unit. He also led programs in diabetes, endocrinology, metabolism, and nutrition in Minneapolis.
Dr. Khan is a member of the Board of Directors of Reckitt Benckiser, Executive Chairman of Life Biosciences, LLC, a member of the Saudi National Biotechnology Strategy Steering Committee, and Chairman of the Visiting Committee on Advanced Technology of the United States’ National Institute of Standards and Technology (NIST).
Dr. Khan earned his medical degree from the University of Liverpool School of Medicine, England, and completed a fellowship in clinical endocrinology and nutrition in the Department of Medicine and Food Science and Nutrition at the University of Minnesota, Minneapolis. He is a Fellow of the Royal College of Physicians in London, a Fellow of the American College of Endocrinology, and an Elected Fellow in the Department of Pharmacology at University of Oxford.
Visit website: https://hevolution.com/en/w/our-management-team
See also
Details last updated 25-Oct-2019
Mehmood Khan News
XPRIZE Launches a $101 Million Healthspan Competition
Live Forever Club - 29-Nov-202310 years of functional age-reversal in 65-80 year olds within the next 7 years... bring it on!!!
Hevolution Foundation to spend $1 billion annually on the biology of aging
MIT Technology Review - 07-Jun-2022Considering funding a $100 million age reversal X Prize and the TAME(metformin) trial
Life Biosciences raises funding to develop innovative therapies against ageing biology
Longevity Technology - 06-Jan-2022Invests $82 million in research platforms, aiming to prevent or reverse age-related diseases
Investing in the Longevity industry
Longevity Technology - 18-Sep-2019Edwards believes 20–30 years will be added to the average lifespan with none of the ageing diseases
Mehmood Khan is also referenced in the following:
Global Healthspan Summit (GHS) 2025
04-Feb-2025
Longevity summit organised by Hevolution Foundation (Riyadh,Saudi Arabia)
Global Healthspan Summit 2023
29-Nov-2023 to 30-Nov-2023
Longevity summit organised by Hevolution Foundation (Riyadh,Saudi Arabia)
Longevity Summit Dublin 2024
13-Jun-2024 to 16-Jun-2024
Event gathering Global Longevity and Rejuvenation community in Dublin by LEV Foundation (Dublin, Ireland)
Rejuvenation Startup Summit 2024
10-May-2024 to 11-May-2024
The leading networking event for rejuvenation startups, longevity investors and translational researchers by Forever Healthy Foundation
XPRIZE Launches a $101 Million Health Competition
Live stream of XPRIZE Healthspan launch on YouTube
